Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
Salt CompositionTirofiban 5mg
Aggrilek Infusion
You Searched
Aggrilek Infusion
J B Chemicals and Pharmaceuticals Ltd.
₹3,832.9
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Used In
Prevention of Heart attack
Customers also bought
More About Aggrilek
Benefits
In Prevention of Heart attack It prevents blood from clotting inside the veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Follow your doctor?s instructions carefully and make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How it works
Aggrilek Infusion is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Aggrilek Infusion . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Safe when prescribed by an expert: Aggrilek Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Caution Advised: Aggrilek Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
NOT RELEVANT - Not relevant, as Aggrilek Infusion is intended for use in hospitalised patients.
Caution Advised: Aggrilek Infusion should be used with caution in patients with kidney disease. Dose adjustment of Aggrilek Infusion may be needed. Doctor consultation is advised.
Caution Advised: Aggrilek Infusion should be used with caution in patients with liver disease. Dose adjustment of Aggrilek Infusion may be needed. Doctor consultation is advised. Use of Aggrilek Infusion is not recommended in patients with severe liver disease.
What if I forget to take it?
If a dose of Aggrilek Infusion is missed, it's advisable to consult your doctor.
Manufacturer Address
Cnergy IT Park, 3rd floor Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025
References
Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 871-72
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. p. 355
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1369-70
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Tirofiban hydrochloride monohydrate. Uxbridge, UK: Correvio UK Ltd.; 1999 (24 Jan. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
